Clin2
NCT07350707Possibly a fitRecruiting

PET scan for Cushing's syndrome using two tracers

Cushing s Syndrome

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests if a special PET scan using two different tracers (68Ga-Pentixafor and 68Ga-DOTATATE) can help diagnose Cushing's syndrome and find its cause. It may help doctors better understand your condition and guide treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
160 people
Ages
10 years to 80 years
Study type
Interventional

Who can take part

  • You have or are suspected to have Cushing's syndrome based on symptoms or abnormal cortisol tests.
  • You are willing to have two PET scans with the injected tracers.
  • You agree to join the study and sign a consent form.
  • No radioactive drugs in the last 5 half-lives before the scan.
  • You are not pregnant or breastfeeding.
  • No known allergy to gallium-based tracers.
  • You are medically stable enough for the scans.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06246357Recruiting· Phase 2
Testing adrenal gland function with a special scan

This trial uses a special PET scan (68Ga-PentixaFor) to check how well your adrenal glands are working if you have high aldosterone or cortisol levels. It helps doctors see if the glands are making too much hormone, which may guide treatment.

Bethesda, Maryland
NCT07605156Recruiting
New imaging scan for rare adrenal hormone tumors

This study tests a special imaging scan (PET/CT) to help doctors identify adrenal tumors that produce too much of two hormones: aldosterone and cortisol. If you have both hormone imbalances confirmed by blood tests and are planning surgery to remove your adrenal gland, this scan may help your doctors see exactly where the tumor is.

Beijing
NCT07138716Recruiting
PET/CT scan for medullary thyroid carcinoma

This study tests a new imaging agent (68Ga-DOTA-CCK-FS) that helps doctors see medullary thyroid carcinoma (MTC) and other tumors with CCK-2 receptors using a PET/CT scan. It may help find or monitor these tumors more clearly.

Beijing, Beijing Municipality
NCT02019706Recruiting· Phase 2
PET/CT scans to find the cause of ectopic Cushing syndrome

This trial tests several special imaging scans to help doctors locate the source of hormone overproduction in ectopic Cushing syndrome. It may help confirm where the problem is so treatment can be better targeted.

Bethesda, Maryland
NCT07460232Recruiting· Early Phase 1
PET scan for Cushing disease pituitary adenomas

This study uses a special PET scan (FET PET/CT) to help find tiny pituitary tumors causing Cushing disease. The goal is to improve surgery planning so the tumor can be removed successfully.

Rochester, Minnesota
NCT07108244Enrolling by invitation
Better brain scan for small pituitary tumors in Cushing's disease

This study tests a special type of brain scan (PET-MRI) to better find tiny pituitary tumors causing Cushing's disease. It may help people whose standard MRI didn't show a clear tumor.

Rotterdam, South Holland

Hear when a new Cushing s Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.